Working… Menu
Trial record 1 of 16 for:    Gantenerumab
Previous Study | Return to List | Next Study

Relative Bioavailability of Gantenerumab Produced by G4 Process Versus G3 Process Following Subcutaneous (SC) Injection in Healthy Participants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03236844
Recruitment Status : Completed
First Posted : August 2, 2017
Last Update Posted : December 12, 2018
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 15, 2017
Actual Study Completion Date : December 15, 2017